Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Targeting the PGD2-DP2 pathway may help treat hair loss.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

8-OHdG may help diagnose and assess alopecia areata.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Androgens significantly affect female hair loss, and hormonal treatments may help.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

Dysregulated lipid metabolism may play a role in male pattern baldness.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Higher aldosterone levels link to hair loss and high blood pressure.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

AMT may cause hair loss and changing dWAT activity could help treat it.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Normal androgen levels need ACTH, and different mechanisms control adrenarche and gonadarche.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Men with a certain type of hair loss (AGA) have higher bad cholesterol and lower good cholesterol levels, making them more likely to get heart disease.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Osteopontin levels are higher in people with androgenetic alopecia and are linked to metabolic disorders.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Hair thickness differences help diagnose hair loss severity.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.